A new formulation of Amphotericin B (AmB) has been shown to be stable in tropical climates and effective in treating Visceral Leishmaniasis (VL) in mouse models.
A new formulation of Amphotericin B (AmB) has been shown to be stable in tropical climates and effective in treating Visceral Leishmaniasis (VL) in mouse models.